Given that MGMT status is well established in adult glial tumor studies as a key predictor of temozolomide efficacy, it was hypothesized that patients undergoing concurrent temozolomide treatment might have harbored MGMT-methylated tumors [10]. The gene discussed is MGMT; the disease is glioma.